Cargando…
RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype
Tumor subtype-specific metabolic reprogrammers could serve as targets of therapeutic intervention. Here we show that triple-negative breast cancer (TNBC) exhibits a hyper-activated cholesterol-biosynthesis program that is strongly linked to nuclear receptor RORγ, compared to estrogen receptor-positi...
Autores principales: | Cai, Demin, Wang, Junjian, Gao, Bei, Li, Jin, Wu, Feng, Zou, June X., Xu, Jianzhen, Jiang, Yuqian, Zou, Hongye, Huang, Zenghong, Borowsky, Alexander D., Bold, Richard J., Lara, Primo N., Li, Jian Jian, Chen, Xinbin, Lam, Kit S., To, Ka-Fai, Kung, Hsing-Jien, Fiehn, Oliver, Zhao, Ruqian, Evans, Ronald M., Chen, Hong-Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789042/ https://www.ncbi.nlm.nih.gov/pubmed/31604910 http://dx.doi.org/10.1038/s41467-019-12529-3 |
Ejemplares similares
-
ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
por: Wang, Junjian, et al.
Publicado: (2016) -
Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling
por: Zhang, Xiong, et al.
Publicado: (2021) -
Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner
por: Zou, Hongye, et al.
Publicado: (2023) -
SUN-751 RORγ Is a Master Regulator of Tumor Lipid Metabolism
por: Chen, Hong-Wu
Publicado: (2020) -
Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop via NRF2 in cancer therapeutic resistance
por: Wang, Hong, et al.
Publicado: (2022)